$NVAX, Concentrate on Analyst’s Ratings: Nov
Post# of 23118
Posted On: 11/01/2016 8:43:18 AM
$NVAX,
Concentrate on Analyst’s Ratings: Novavax, Inc. (NASDAQ:NVAX)
0
By Martin Almanza on November 1, 2016 Business
10/31/2016, Novavax, Inc. (NASDAQ:NVAX) stock dropped +5.56% or +0.08 points. After the session opened at $1.45, the stock’s price hit the top of $ 1.57 while it touched a low of $ 1.42. Total 6.05 million shares changed on hands and it kept the average volume of 17.65 million shares. The previous close of the stock was called at $1.44.
The company has encountered a twelve month cheapest price of $ 1.16 and hit a twelve month expensive price of $ 9.23. The stock’s price to price to book (P/
ratio for most recent quarter was disclosed as 3.54 and its price to sales (P/S) ratio for the last one year was 20.42.
Company’s Snapshot:
Shares of NVAX have been given average recommendation of “Hold” rating keeping in view the consensus of “8” Analysts. The mean price target for the stock is listed at $5.02. Mean EPS estimate for the Current Quarter is placed at $-0.26 and mean EPS forecast for the Current Year is set at $-1.09. The company reported Earnings of $-0.29 in last Quarter’s while the company declared Earnings of $-0.44 in past year. EPS Estimate for Next Fiscal Year is stands at $-0.81. Median PE on CY Estimate is noted at 9999 while Median PE on Next FY Estimate is recorded at 9999.
Earnings Expectations:
This Quarter
For this stock, Analysts estimated the Higher, Lower and Mean EPS forecast. Mean Earnings Per Share (EPS) forecast is set at $-0.26 by these analysts for This Quarter. Higher EPS estimate that can be reached in this quarter is determined at $-0.23 and lower forecasted EPS is placed at $-0.29. The mean EPS is calculated keeping in view the consensus of 8 Analysts. Coefficient Variance is noted at -7.55.
Next Quarter
Analysts also projected the Maximum, Minimum and Mean Earnings per share Estimate for Next Quarter. The Mean EPS forecast of 8 analysts for Next Quarter is set at $-0.25. Maximum EPS estimate that expected in next quarter is noted at $-0.2 and minimum forecasted EPS is calculated at $-0.31. Coefficient Variance is measured at -15.17.
This Fiscal
Financial Analysts Projected EPS targets for This Fiscal Year. 8 Financial Analysts covered the company’s stock. Mean (EPS) target is set at $-1.09. Higher EPS forecast that can be expected in this Fiscal Year is noted at $-1.02 and a lower EPS estimate is calculated at $-1.16. Coefficient Variance is measured at -4.94.
Next Fiscal Year
Mean EPS estimate of 8 analysts for Next Fiscal Year is placed at $-0.81. Maximum EPS estimate that projected in Next Fiscal Year is recorded at $-0.56 and minimum forecasted EPS is calculated at $-1.13. Coefficient Variance is noted at -21.96.
Analysts Recommendations
Current
The stock has received different ratings from Financial Analysts. Recently, stock has been recommended as BUY from 2 and 0 given OVERWEIGHT rating for the company.6 issued rating as a HOLD.0 said as SELL recommendation and 0 suggested UNDERWEIGHT rating. The shares have been given a mean Hold rating keeping in view the consensus of 8 Analysts.
Concentrate on Analyst’s Ratings: Novavax, Inc. (NASDAQ:NVAX)
0
By Martin Almanza on November 1, 2016 Business
10/31/2016, Novavax, Inc. (NASDAQ:NVAX) stock dropped +5.56% or +0.08 points. After the session opened at $1.45, the stock’s price hit the top of $ 1.57 while it touched a low of $ 1.42. Total 6.05 million shares changed on hands and it kept the average volume of 17.65 million shares. The previous close of the stock was called at $1.44.
The company has encountered a twelve month cheapest price of $ 1.16 and hit a twelve month expensive price of $ 9.23. The stock’s price to price to book (P/
ratio for most recent quarter was disclosed as 3.54 and its price to sales (P/S) ratio for the last one year was 20.42. Company’s Snapshot:
Shares of NVAX have been given average recommendation of “Hold” rating keeping in view the consensus of “8” Analysts. The mean price target for the stock is listed at $5.02. Mean EPS estimate for the Current Quarter is placed at $-0.26 and mean EPS forecast for the Current Year is set at $-1.09. The company reported Earnings of $-0.29 in last Quarter’s while the company declared Earnings of $-0.44 in past year. EPS Estimate for Next Fiscal Year is stands at $-0.81. Median PE on CY Estimate is noted at 9999 while Median PE on Next FY Estimate is recorded at 9999.
Earnings Expectations:
This Quarter
For this stock, Analysts estimated the Higher, Lower and Mean EPS forecast. Mean Earnings Per Share (EPS) forecast is set at $-0.26 by these analysts for This Quarter. Higher EPS estimate that can be reached in this quarter is determined at $-0.23 and lower forecasted EPS is placed at $-0.29. The mean EPS is calculated keeping in view the consensus of 8 Analysts. Coefficient Variance is noted at -7.55.
Next Quarter
Analysts also projected the Maximum, Minimum and Mean Earnings per share Estimate for Next Quarter. The Mean EPS forecast of 8 analysts for Next Quarter is set at $-0.25. Maximum EPS estimate that expected in next quarter is noted at $-0.2 and minimum forecasted EPS is calculated at $-0.31. Coefficient Variance is measured at -15.17.
This Fiscal
Financial Analysts Projected EPS targets for This Fiscal Year. 8 Financial Analysts covered the company’s stock. Mean (EPS) target is set at $-1.09. Higher EPS forecast that can be expected in this Fiscal Year is noted at $-1.02 and a lower EPS estimate is calculated at $-1.16. Coefficient Variance is measured at -4.94.
Next Fiscal Year
Mean EPS estimate of 8 analysts for Next Fiscal Year is placed at $-0.81. Maximum EPS estimate that projected in Next Fiscal Year is recorded at $-0.56 and minimum forecasted EPS is calculated at $-1.13. Coefficient Variance is noted at -21.96.
Analysts Recommendations
Current
The stock has received different ratings from Financial Analysts. Recently, stock has been recommended as BUY from 2 and 0 given OVERWEIGHT rating for the company.6 issued rating as a HOLD.0 said as SELL recommendation and 0 suggested UNDERWEIGHT rating. The shares have been given a mean Hold rating keeping in view the consensus of 8 Analysts.
(0)
(0)
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'